43 Kd protein vaccine and method for the production thereof

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Conjugate or complex

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

4241901, 4241921, 4241931, 4241941, 530350, A61K 39385

Patent

active

059119969

ABSTRACT:
A protein derivable from Actinobacillus pleuropneumoniae (APP) having a molecular size ranging between 43 Kd on SDS PAGE is described. The protein is soluble on sodium lauryl sarcosinate (SLS) and not heat modifiable. The protein can also be derived by recombinant methods. The protein in a vaccine provides immunity against multiple serotypes of APP.

REFERENCES:
Mulks, M., and Thacker, B., in Proc. Int. Pig Veter. Soc. 10 81 (1988).
P. J. Fedorka-Cray, M. J. Huether, D. L. Stine, and G. A. Anderson. Effidacy of a cell extract form Actinobacillus (Haemophilus) pleuropneumoniae serotype 1 against disease in swine. Infect. Immun. 58:358-365 (1990).
J. Devenish, S. Rosendal, and J. T. Bosse, Humoral antibody response and protective immunity in swine following immunization with the 104 kildalton hemolysin of Actinobacillus pleuropneumoniae Infect. Immuno. 58:3829-3832 (1990).
D. K. Lenser, T. L. McDonald, and N. G.Miller. Veter. Microbiol. 18:335-348 (1988).
Sanger, F., et al., PNAS 74:5463-5467 (1977).
Markmeyer, P., et al., Gene 93, 129-134 (1990).
Thwaits et al., Infection and Immunity, vol. 59, No. 2, Feb. 1991, pp. 544-549.
Young et al., Proc. Natl. Acad. Sci. USA, vol. 80, pp. 1194-1198, Mar. 1983.
Mulks et al., Abstracts of the 91st General Meeting of the American Society for Microbiology, 1991, D-230.
Mierendorf et al., Methods in Enzymology, vol. 152, 1987, pp. 458-469.
Uhlen et al., Methods in Enzymology, vol. 185, 1990, pp. 129-143.
Deneer et al., Vet. Inf. Inf. Dig. Org. Saskatoon, Saskatchewan, Canada, Microbial Pathogenesis, 1989, vol. 6, No. 6, pp. 425-432.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

43 Kd protein vaccine and method for the production thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 43 Kd protein vaccine and method for the production thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 43 Kd protein vaccine and method for the production thereof will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-400988

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.